Safety, Pharmacokinetics, and Antiviral Activity of a Novel HIV Antiviral, ABX464, in Treatment-Naive HIV-Infected Subjects in a Phase 2 Randomized, Controlled Study
about
Safety, Pharmacokinetics, and Antiviral Activity of a Novel HIV Antiviral, ABX464, in Treatment-Naive HIV-Infected Subjects in a Phase 2 Randomized, Controlled Study
description
2017 nî lūn-bûn
@nan
2017 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Safety, Pharmacokinetics, and ...... 2 Randomized, Controlled Study
@ast
Safety, Pharmacokinetics, and ...... 2 Randomized, Controlled Study
@en
type
label
Safety, Pharmacokinetics, and ...... 2 Randomized, Controlled Study
@ast
Safety, Pharmacokinetics, and ...... 2 Randomized, Controlled Study
@en
prefLabel
Safety, Pharmacokinetics, and ...... 2 Randomized, Controlled Study
@ast
Safety, Pharmacokinetics, and ...... 2 Randomized, Controlled Study
@en
P2093
P2860
P356
P1476
Safety, Pharmacokinetics, and ...... 2 Randomized, Controlled Study
@en
P2093
Didier Scherrer
Hartmut Ehrlich
Jamal Tazi
Jean-Marc Steens
P Noel Barrett
Paul Gineste
Ratanasuwan Winai
Supparatpino Khuanchai
P2860
P356
10.1128/AAC.00545-17
P407
P577
2017-05-15T00:00:00Z